公司資料
Processa Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- PCSA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
2.13 USD (-12.35%)
收盤價
最後更新: 2026年8月17日
8.03M USD
市值
股價為何變動
As of Aug 17, 2026, PCSA closed down 12.3% at $2.13. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Processa Pharmaceuticals is a development-stage company focused on improving the safety and efficacy of existing oncology drugs through next-generation formulations and combinations. Its story centers on making known medicines more usable in difficult cancer settings.
所在地與產業分類
Processa is headquartered in the United States and listed on NASDAQ. It sits in small-cap biopharmaceutical development.
商業模式特徵
The business depends on clinical progress, formulation strategy, and the ability to advance a narrow pipeline with limited resources. Investors typically watch proof-of-concept data and partnership or financing activity.
生技產業定位
Processa occupies a niche oncology-development position within biotech. It is a small-cap story where the commercial value depends on whether modified therapies can truly improve outcomes.
未來催化劑
- Processa’s catalysts are its rare-disease and oncology programs, especially any development update that clarifies which assets still matter. The company needs a cleaner clinical path.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。